Skip to main content

Table 6 Mortality and mRS and characteristics of the patients

From: Incidence and predictive factors of diaphragmatic dysfunction in acute stroke

 MortalitymRS
Mortality n (%)No n (%)pGood pr. n (%)Poor pr. n (%)p
Female sex3 (10.3)26 (89.7)0.66619 (65.5)10 (34.5)0.855
Hypertension4 (10.5)34 (89.5)0.64323 (60.5)15 (39.5)0.185
Dyslipidaemia3 (10.7)25 (89.3)0.53317 (60.7)11 (39.3)0.360
Diabetes3 (16.7)15 (83.3)0.15410 (55.6)8 (44.4)0.232
Smoking020 (100)0.09918 (90)2 (10)0.008
Poor performance status3 (12.5)21 (87.5)0.38014 (58.3)10 (41.7)0.264
Previous severe dyspnoea03 (100)11 (33.3)2 (66.7)0.255
COPD04 (100)12 (50)2 (50)0.595
SAHS06 (100)14 (66.7)2 (33.3)1
Cardioembolic origin042 (100)0.00232 (76.2)10 (23.8)0.034
Sensory aphasia1 (20)4 (80)0.36305 (100)0.003
Reperfusion treatment3 (12)22 (82)0.64015 (60)10 (40)0.412
Severe hemiparesis1 (2.1)47 (97.9)0.00438 (79.2)10 (20.8)<  0.001
Age, mean ± SD69.5 ± 10.568.9 ± 9.40.87267.2 ± 8.973.4 ± 10.10.288
NIHSS, median [25%:75%]21 [18.5:24]4 [3:9]<  0.0014 [2:8]10 [5:20]0.006
TF basal breathing %, mean ± SD0.14 ± 0.040.28 ± 0.19<  0.0010.31 ± 0.200.19 ± 0.130.004
TF forced inspiration %, mean ± SD0.40 ± 0.060.48 ± 0.250.1430.51 ± 0.260.40 ± 0.200.061
Mortality05 (100)0.003
RI5 (8.3)28 (84.8)0.04317 (51.7)16 (48.5)0.007
  1. The table shows the association between mortality and mRS at 3 months and the demographic and clinical characteristics of the patients. The statistically significant results are highlighted in bold
  2. COPD Chronic Obstructive Pulmonary Disease, IQ Interquartile range, mRS Modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, pr Prognosis, RI Respiratory impairment, SAHS Sleep Apnoea-Hypopnoea Syndrome, SD Standard deviation, TF Thickening fraction